Company Ion Beam Applications, SA
Equities
IBAB
BE0003766806
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.48 EUR | +2.74% |
|
+0.60% | +0.45% |
Feb. 07 | Ion Beam Applications, Framatome Partner to Produce Cancer Therapy Radioisotope | MT |
Feb. 07 | Framatome, IBA To Partner To Develop An Astatine-211 Cyclotron Network | RE |
Business description: Ion Beam Applications, SA
- diagnosis and therapeutic treatment equipment and systems (84.8%): proton therapy equipment (62.5% of net sales; No. 1 worldwide), and particle accelerators (36.5%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®);
- equipment and solutions of dosimetry (15.2%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy.
Net sales are distributed geographically as follows: the United States (31.7%) and other (68.3%).
Number of employees: 1,943
Sales by Activity: Ion Beam Applications, SA
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Proton Therapy and Other Accelerators | 229M | 261M | 261M | 307M | 366M |
Dosimetry | 53.85M | 51.06M | 52.33M | 53.97M | 65.91M |
Eliminations | - | - | - | - | -3.62M |
Geographical breakdown of sales: Ion Beam Applications, SA
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Rest of World | 184M | 237M | 225M | 229M | 293M |
USA | 88.77M | 72.89M | 81.99M | 128M | 136M |
Belgium | 9.36M | 2.49M | 5.67M | 4.25M | -243K |
Managers: Ion Beam Applications, SA
Director | Title | Age | Since |
---|---|---|---|
Olivier Legrain
CEO | Chief Executive Officer | 57 | 2012-04-30 |
Yves Jongen
CTO | Chief Tech/Sci/R&D Officer | 77 | 1986-03-27 |
Christian Matton
LAW | General Counsel | - | 2017-12-31 |
Corporate Officer/Principal | - | 2023-10-31 |
Members of the board: Ion Beam Applications, SA
Manager | Title | Age | Since |
---|---|---|---|
Pierre Mottet
CHM | Chairman | 64 | 2013-04-30 |
Yves Jongen
BRD | Director/Board Member | 77 | 1991-04-30 |
Olivier Legrain
BRD | Director/Board Member | 57 | 2012-04-30 |
Marcel Miller
BRD | Director/Board Member | 72 | 2011-04-30 |
Director/Board Member | - | 2015-04-30 | |
Hedvig Hricak
BRD | Director/Board Member | 78 | 2017-04-30 |
Christine Dubus
BRD | Director/Board Member | 61 | 2020-08-31 |
Richard Hausmann
BRD | Director/Board Member | 65 | 2020-08-31 |
Holdings: Ion Beam Applications, SA
Name | Equities | % | Valuation |
---|---|---|---|
1,152,754 | 3.81% | 16,019,142 $ |
Company details: Ion Beam Applications, SA
Ion Beam Applications SA
3, chemin du Cyclotron
1348, Louvain-la-Neuve
+32 1 047 58 11
http://www.iba-worldwide.com
Group companies: Ion Beam Applications, SA
Name | Category and Sector |
---|---|
IBA Dosimetry GmbH
![]() IBA Dosimetry GmbH Medical SpecialtiesHealth Technology Part of Ion Beam Applications SA, IBA Dosimetry GmbH is a German company that offers a full range of innovative high-quality solutions to maximize efficiency and minimize errors in radiation therapy and medical imaging. The company is based in Schwarzenbruck, Germany. IBA Dosimetry specializes in 3D Water Phantom System for complete LINAC Commissioning & QA with unique absolute measurement technology. The company also provides advanced beam verification and quality assurance for all x-ray imaging modalities. The CEOs of the company are Soumya Chandramouli, Olivier Legrain, Jean-Marc Bothy. |
Medical Specialties
|
IBA Investments SCRL
|
Other Advanced Medical Equipment & Technology
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+2.74% | +0.60% | +36.71% | -20.89% | 407M | ||
-0.22% | -4.40% | +3.47% | -2.65% | 219B | ||
-0.94% | +1.94% | +48.96% | +104.63% | 208B | ||
+0.22% | +2.82% | +61.35% | +145.28% | 155B | ||
-1.55% | -7.17% | -16.17% | -27.49% | 149B | ||
-1.61% | +2.29% | +4.23% | -1.40% | 65.07B | ||
+4.66% | +8.09% | -16.55% | -23.55% | 41.68B | ||
-0.90% | -2.90% | -18.77% | -36.70% | 41.49B | ||
-1.65% | -4.16% | +9.35% | +3.45% | 41.43B | ||
-1.03% | -0.75% | +7.10% | - | 40.04B | ||
Average | -0.03% | -0.44% | +11.97% | +15.63% | 96.04B | |
Weighted average by Cap. | -0.52% | -1.10% | +18.27% | +40.38% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IBAB Stock
- Company Ion Beam Applications, SA